期刊文献+

2-methoxyestradiol通过反应性氧基对U937白血病细胞的凋亡诱导作用

2-methoxyestradiol-induced apoptosis in U937 cells through generation of reactive oxygen species
下载PDF
导出
摘要 目的:探讨2-ME诱导U937白血病细胞凋亡的作用和机制。方法:实验分为白血病细胞株U937细胞含有等量DMSO RPMI 1640培养液的对照组、2-ME处理组、NAC处理组和2-ME+NAC处理组。MTT测定评价对U937细胞毒作用;采用Annexin V和NO染料标记细胞,流式细胞术检测细胞内NO生成和细胞凋亡;DHE测定细胞内超氧阴离子。结果:不同浓度2-ME(0.25、0.50、1.00、和2.00μmol.L-1)处理U937细胞48 h后,U937细胞活性均较对照组明显减少(P<0.05),随着2-ME浓度的增高,U937细胞的生存率逐渐减低,呈剂量依赖性。2-ME(2.00μmol.L-1)处理U937细胞8、12、18和24 h后的细胞凋亡率均高于对照组(P<0.05),随着处理时间的延长,细胞凋亡率逐渐升高;而2-ME处理U937细胞1、3及6 h后的细胞凋亡率与对照组比较差异均无显著性(P>0.05)。2-ME(2.00μmol.L-1)处理U937细胞产生NO荧光值显著增加,超氧阴离子为1.21±0.02,与对照组比较差异具有显著性(P<0.05)。2-ME处理U937细胞1 h时,细胞NO阳性率是46.74%±0.15%,与对照组(0.52%±0.21%)比较差异具有显著性(P<0.05);而细胞凋亡率(1.28%±0.07%)与对照组(1.59%±0.12%)比较差异无显著性(P>0.05);2-ME处理U937细胞3 h后,细胞凋亡率高于对照组(P<0.05),提示U937细胞NO的产生早于细胞凋亡。用NAC抑制反应性氧基(ROS)可保护U937细胞逃避2-ME的细胞毒作用和避免2-ME诱导的细胞凋亡。2-ME(2.00μmol.L-1)处理组U937细胞活性和细胞凋亡率分别是0.47%±0.02%和13.87%±0.69%,与对照组和2-ME+NAC处理组(0.82%±0.08%及2.98%±0.19%)比较差异均具有显著性(P<0.05)。结论:2-ME通过ROS诱导U937细胞凋亡,提示产生ROS的物质可能增强抗白血病作用。 Objective To investigate the effect of 2-methoxyestradiol (2-ME) on U937 myeloid leukemia cell line and its mechanism. Methods The experiment was divided into control group (myeloid leukemia U937 cell in RPMI 1640 culture medium with equal DMSO), 2-ME-treated group, NAC-treated group, and 2-ME + NAC-treated group. The cytotoxicity was analyzed by MTT assay. Apoptosis and cellular nitric oxide (NO) were detected by flow cytometry using annexin V and NO sensor dye. Superoxide anion was measured with a fluorescent plate reader by DHE. Results Viabilities of U937 cells treated with 2-ME (0. 25, 0.50, 1.00, and 2.00 μmol·L^-1) for 48 h were gradually reduced to 0. 68±0. 05, 0.28±0.07, 0.18±0.07, and 0.11±0. 04 , respectively. The differences were significant compared with control group ( 1.00 ±0.05) (P(0.05). 2-ME resulted in viability decrease in a dose-dependent manner. The apoptotic rates in 2-ME (2.00 μmol · L^-1) -treated group were 4.64%±0.21%, 9.86%±0.9%, 14.62%±0.67%, and 19.49%±0.90% at 8, 12, 18, and 24 h time points, respectively, and significantly higher than that in control group (1.74% ±0.08%) (P〈0.05) . There were no significant differences ofapoptotic rate between 2-ME-treated group and control group at 1, 3, and 6 h time points (P〉0.05) . 2.00 μmol · L^-1 2-ME also significantly increased the mean fluorescence of NO sensor dye and superoxide anions in U937 cells compared with control group (P〈0.05) . The percentage of NO positive cells increased from 0.52% ±0.21% to 46.74% ±0.15% after treatment for 1 h with 2.00μmol · L^-1 2-ME (P〈 0.05), whereas, there was no significant difference of apoptotic cells at this point between 2-ME group and control group (1, 28% ±0.07% vs 1.59% ±0.12%, P〉0.05) . An markedly increase in apoptotic cells was detected after 2-ME treatment for 3 h (6.78% ±1.01% vs 1.59% ± 0.12%, P〈0.05) . These results indicated that the generation of NO was earlier than apoptosis underwent. Furthermore, quenching of ROS with NAC protected leukemia cells from the cytotoxicity of 2-ME and prevented apoptosis induced by 2-ME. The viabilities and apoptotic rate of 2.00 μmol · L^-1 2-ME- treated group were 0. 47±0. 02 and 13. 87±0. 69%, respectively. The differences were significant compared with control group or 2-ME + NAC group ( 0. 82 ±0. 08 and 2.98%±0. 19%, respectively) (P 〈 0. 05). Conclusion 2-ME can induce apoptosis in U937 cells through generation of ROS. It is possible to use ROS- generation agents to enhance the antileukemic effect.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期469-473,共5页 Journal of Jilin University:Medicine Edition
基金 广东省科技厅自然科学基金资助课题(7001196) 广东省卫生厅资助课题(A2006020)
关键词 白血病 2-methoxyestradi01 凋亡 反应性氧基 一氧化氮 超氧化物离子 leukemia 2-methoxyestradiol apoptosis reactive oxygen species nitric oxide superoxide anion
  • 相关文献

参考文献9

  • 1Schumacher G, Neuhaus P. 2-Methoxyestradiol - a new compound for cancer treatment [J] . Dtsch Med Wochenschr, 2006, 131 (15):825-830.
  • 2高巍然,侯健,熊红.2-甲氧基雌二醇对原代骨髓瘤细胞分化的作用[J].中国实验血液学杂志,2006,14(2):262-266. 被引量:3
  • 3Ray G, Dhar G, van Veldhuizen PJ, et al. Modulation of cellcycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways [J]. Biochemistry, 2006, 45 (11): 3703-3713.
  • 4Garcia GE, Wisniewski HG, Lucia MS, et al. 2- Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6 [J]. Clin Cancer Res, 2006, 12 (3 Pt 1): 980-988.
  • 5Perez-Stable C. 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells [J]. Cancer Lett, 2006, 231 (1):49-64.
  • 6Huang P, Feng L, Oldham EA, et al. Superoxide dismutase as a target for the selective killing of cancer cells [J]. Nature, 2000, 407 (6802):390-395.
  • 7Koumura T, Nakamura C, Nakagawa Y. Role of calciuminduced mitochondrial hydroperoxide in induction of apoptosis of RBL2H3 cells with eicosapentaenoic acid treatment [J]. FreeRadicRes, 2005, 39 (10): 1083-1089.
  • 8Pan J, She M, Xu ZX, et al. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells[J]. Cancer Res, 2005, 65 (9): 3671-3681.
  • 9She M, Pan I, Sun L, et al. Enhancement of manumycin Ainduced apoptosis by methoxyamine in myeloid leukemia cells [J]. Leukemia, 2005, 19 (4): 595-602.

二级参考文献12

  • 1张之南 忱悌.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1999.270-271.
  • 2Witzig TE,Timm M,Larson D,et al.Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders.Br J Haematol,1999; 104:131-137.
  • 3Hallek M,Bergsagel PL,Anderson KC.Multiple myeloma:increasing evidence for a multistep transformation process.Blood,1998;91:3 -21.
  • 4Miltenyi S,Muller W,Weichel W,et al.High gradient magnetic cell separation with MACS.Cytometry,1990;11:231 -238.
  • 5Carey DJ.Syndecans:multifunctional cell-surface co-receptors.Biochem J,1997; 327 (Pt 1):1-16.
  • 6Klein B.Cytokines,cytokine receptors,transduction signals and onco-genes in human multiplel.Semin Hematol,1995; 32:4 -5.
  • 7Dhodapkar MV,Abe E,Theus A,et al.Syndecan-1 is a multifunctional regulator of myeloma pathobiology:control of tumor cell survival,growth,and bone cell differentiation.Blood,1998; 91:2679-2688.
  • 8Greipp PR,Raymond NM,Kyle RA,et al.Multiple myeloma:significance of plasmablastic subtype in morphological classification.Blood,1985; 65:305-310.
  • 9Van-Riet I,Van-Camp B.The involvement of adhesion molecules in the biology of multiple myeloma.Leuk Lymphoma,1993; 9:441 -452.
  • 10Ishikawa H,Kawano MM.Biological significance of heterogeneity in human myeloma cells.Int J Hematol,1998; 68:363 -370.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部